Evidence map›Paper›PMID 18391992›Full record

ArticleBone marrow transplantation2008

Rituximab-responsive Guillain-Barré syndrome following allogeneic hematopoietic SCT.

F Ostronoff, M-A Perales, M D Stubblefield, K C Hsu

Open access · bronzeAbstract readCase ReportsLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Bone marrow transplantation, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
0.4field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Immunoglobulin and Monoclonal Antibody Therapies in Guillain-Barré Syndrome.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2022
    Review
  6. Review
  7. Review
  8. Peripheral nerve disease secondary to systemic conditions in children.Therapeutic advances in neurological disorders · 2019
    Review
  9. [Paraplegia after hematopoietic stem cell transplantation].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2017
    Article
  10. Review
  11. Article
  12. New strategies in the management of Guillain-Barré syndrome.Clinical reviews in allergy & immunology · 2014
    Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

F Ostronoff
M-A Perales
M D Stubblefield
K C Hsu
Memorial Sloan Kettering Cancer Center · USCornell University · US

Funding

NK Receptors and Bone Marrow Transplant OutcomeK23HL070053 · NHLBI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI HSU, KATHARINE C · 2004 to 2008
$646k
NHLBI NIH HHS HL070053NHLBI NIH HHS K23 HL070053
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antibodies, MonoclonalAntibodies, Monoclonal, Murine-DerivedGuillain-Barre SyndromeHematopoietic Stem Cell TransplantationHerpesvirus 4, HumanHumansImmunologic FactorsMaleMiddle AgedRituximabTransplantation, HomologousViremiaAntibodies, MonoclonalAntibodies, Monoclonal, Murine-DerivedImmunologic FactorsRituximab

Identifiers

PMID18391992
PMCPMC4445357
OpenAlexW2093321168

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.